[go: up one dir, main page]

NO20090405L - Ikke-nukleoside revers transcriptase inhibitorer - Google Patents

Ikke-nukleoside revers transcriptase inhibitorer

Info

Publication number
NO20090405L
NO20090405L NO20090405A NO20090405A NO20090405L NO 20090405 L NO20090405 L NO 20090405L NO 20090405 A NO20090405 A NO 20090405A NO 20090405 A NO20090405 A NO 20090405A NO 20090405 L NO20090405 L NO 20090405L
Authority
NO
Norway
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleoside reverse
compounds
hiv infection
Prior art date
Application number
NO20090405A
Other languages
English (en)
Norwegian (no)
Inventor
Wylie Solang Palmer
Zachary Kevin Sweeney
Joshua Kennedy-Smith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20090405L publication Critical patent/NO20090405L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20090405A 2006-08-16 2009-01-28 Ikke-nukleoside revers transcriptase inhibitorer NO20090405L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83827206P 2006-08-16 2006-08-16
PCT/EP2007/058116 WO2008019968A1 (fr) 2006-08-16 2007-08-06 Inhibiteurs de la transcriptase inverse non nucléoside

Publications (1)

Publication Number Publication Date
NO20090405L true NO20090405L (no) 2009-01-30

Family

ID=38663155

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090405A NO20090405L (no) 2006-08-16 2009-01-28 Ikke-nukleoside revers transcriptase inhibitorer

Country Status (23)

Country Link
US (2) US7713974B2 (fr)
EP (1) EP2057125B1 (fr)
JP (1) JP5216768B2 (fr)
KR (1) KR101401811B1 (fr)
CN (1) CN101501002B (fr)
AR (1) AR062366A1 (fr)
AT (1) ATE503744T1 (fr)
AU (1) AU2007286345B2 (fr)
BR (1) BRPI0715193A2 (fr)
CA (1) CA2658984C (fr)
CL (1) CL2007002346A1 (fr)
DE (1) DE602007013573D1 (fr)
DK (1) DK2057125T3 (fr)
ES (1) ES2360893T3 (fr)
IL (1) IL196655A (fr)
MX (1) MX2009001198A (fr)
NO (1) NO20090405L (fr)
PE (1) PE20080734A1 (fr)
PL (1) PL2057125T3 (fr)
PT (1) PT2057125E (fr)
RU (1) RU2451676C2 (fr)
TW (1) TWI417293B (fr)
WO (1) WO2008019968A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
TW200831085A (en) * 2006-12-13 2008-08-01 Merck & Co Inc Non-nucleoside reverse transcriptase inhibitors
MX2009010932A (es) * 2007-04-09 2009-10-29 Hoffmann La Roche Inhibidores no nucleosidos de transcriptasa inversa.
WO2009067597A1 (fr) * 2007-11-21 2009-05-28 Decode Genetics Ehf Dérivés de catéchols substitués en position 4 (ou 5)
AU2008340422B2 (en) * 2007-12-21 2014-06-19 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
WO2010059771A1 (fr) 2008-11-20 2010-05-27 Osi Pharmaceuticals, Inc. Pyrrolo[2,3-b]-pyridines et pyrrolo[2,3-b]-pyrazines substituées
EP2569315A1 (fr) * 2010-05-14 2013-03-20 OSI Pharmaceuticals, LLC Inhibiteurs de kinases bicycliques fusionnés
AR081039A1 (es) 2010-05-14 2012-05-30 Osi Pharmaceuticals Llc Inhibidores biciclicos fusionados de quinasa
US20120142627A1 (en) * 2010-12-06 2012-06-07 Emory University Monophosphate prodrugs of dapd and analogs thereof
US9487506B2 (en) * 2011-04-13 2016-11-08 Merck Sharp & Dohme Corp. Mineralocorticoid receptor antagonists
WO2012148999A1 (fr) 2011-04-26 2012-11-01 The Procter & Gamble Company Eléments absorbants gonflant
SG11201406853SA (en) 2012-04-25 2014-11-27 Procter & Gamble Apparatus and process for aperturing and stretching a web
EP2841039B1 (fr) 2012-04-25 2021-02-24 The Procter and Gamble Company Bande ondulée et ouverte
WO2014091265A1 (fr) 2012-12-11 2014-06-19 Aurigene Discovery Technologies Limited Dérivés de pyrimidine-2,4-diamine en tant qu'inhibiteurs de kinase
JP6321965B2 (ja) 2014-01-09 2018-05-09 富士フイルム株式会社 有機薄膜トランジスタ、有機半導体薄膜および有機半導体材料
CN106614663A (zh) * 2016-12-29 2017-05-10 新沂市中诺新材料科技有限公司 一种新型纳米级吲唑类农药合成方法
CN113511960A (zh) * 2021-08-20 2021-10-19 郑州华赞医药科技有限公司 一种1-氯-3-甲氧基-5-甲基苯的合成方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
US4949314A (en) 1966-08-16 1990-08-14 The United States Of America As Represented By The Secretary Of The Navy Method and means for increasing echo-ranging-search rate
US3682932A (en) 1970-11-23 1972-08-08 Hoffmann La Roche 2-chloro-6-hydroxynicotinic acid
US4211771A (en) 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US4189718A (en) * 1978-03-02 1980-02-19 Carson Manufacturing Company, Inc. Electronic siren
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
GB8327880D0 (en) 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
US4530787A (en) 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4604377A (en) 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
US4569790A (en) 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
US4752585A (en) 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
US4748234A (en) 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
AU622926B2 (en) 1988-09-09 1992-04-30 Nippon Kayaku Kabushiki Kaisha Pyrimidine or purine cyclobutane derivatives
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5489697A (en) 1994-08-03 1996-02-06 Medichem Research, Inc. Method for the preparation of (+)-calanolide A and intermediates thereof
CN1093535C (zh) 1994-09-26 2002-10-30 盐野义制药株式会社 咪唑衍生物
TR199700801T1 (xx) 1995-02-16 1998-03-21 F. Hoffmann-La Roche Ag �nterleukin 12 kullan�larak angiogenesisin �nlenmesi.
IL117574A0 (en) 1995-04-03 1996-07-23 Bristol Myers Squibb Co Processes for the preparation of cyclobutanone derivatives
WO2000016625A1 (fr) 1998-09-23 2000-03-30 University Of Kentucky Research Foundation Compositions medicamenteuses antivirales contenant des sels inorganiques de lithium
FR2783826B1 (fr) 1998-09-29 2002-07-19 Rhodia Chimie Sa Procede de preparation de 4-hydroxyquinoleines et/ou formes tautomeres
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
DE60021370C5 (de) 1999-05-04 2007-11-08 Schering Corp. Piperazinderivate verwendbar als ccr5 antagonisten
ES2246233T3 (es) 1999-05-04 2006-02-16 Schering Corporation Derivados de piperidina utiles como antagonistas de ccr5.
GEP20063799B (en) 2000-05-26 2006-04-25 Pfizer Tropane derivatives useful in therapy
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) * 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
US6620586B2 (en) 2001-02-20 2003-09-16 Applied Gene Technologies, Inc. Methods and compositions for analyzing nucleic acids
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
GB0108046D0 (en) 2001-03-30 2001-05-23 Astrazeneca Ab Chemical compounds
HU229025B1 (en) 2001-04-10 2013-07-29 Pfizer Pyrazole derivatives for treating hiv, pharmaceutical compositions containing them and process for their preparation
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
GB0127547D0 (en) 2001-11-16 2002-01-09 Astrazeneca Ab Chemical compounds
SE0200919D0 (sv) 2002-03-25 2002-03-25 Astrazeneca Ab Chemical compounds
SE0202483D0 (sv) 2002-08-21 2002-08-21 Astrazeneca Ab Chemical compounds
MXPA05003195A (es) 2002-09-26 2005-06-08 Pfizer Derivados de pirazol como inhibidores de la transcriptasa inversa.
ATE386741T1 (de) 2002-09-26 2008-03-15 Pfizer Pyrazolamide zur behandlung von hiv-infektionen
GB0223234D0 (en) 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
GB0223232D0 (en) 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
AR042628A1 (es) 2002-12-20 2005-06-29 Astrazeneca Ab Derivados de piperidina como moduladores del receptor ccr5
TW200423930A (en) 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
KR20050119652A (ko) 2003-03-24 2005-12-21 에프. 호프만-라 로슈 아게 역전사 효소 저해제로서의 벤질-피리다진온
TW200505441A (en) * 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
BRPI0507586A (pt) 2004-02-10 2007-07-03 Hoffmann La Roche moduladores de receptor de quimiocina ccr5
CA2559552A1 (fr) 2004-03-23 2005-09-29 F. Hoffmann-La Roche Ag Derives benzyl-pyridazinone servant d'inhibiteurs d'une transcriptase inverse non nucleosidique
US7166738B2 (en) 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
RU2006146608A (ru) 2004-06-09 2008-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) ОКТАГИДРОПИРРОЛО[3,4-с]-ПРОИЗВОДНЫЕ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ АГЕНТОВ
WO2006010545A1 (fr) 2004-07-27 2006-02-02 F. Hoffmann-La Roche Ag Composes de benzyltriazolone utilises comme inhibiteurs de la transcriptase inverse non-nucleoside
CA2577144C (fr) 2004-09-30 2011-06-21 Boehringer Ingelheim International Gmbh Derives de benzophenone a base d'alkynyle utilises comme inhibiteurs de transcriptase inverse de non nucleoside
EP1831157A2 (fr) 2004-12-22 2007-09-12 Pfizer Limited Inhibiteurs non-nucléosidiques de la transcriptase inverse du vih-1
WO2006099978A1 (fr) 2005-03-24 2006-09-28 F.Hoffmann-La Roche Ag Composes 1,2,4-triazole-5-one comme inhibiteurs de la transcriptase inverse heterocyclique
AR057455A1 (es) 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
DE602006004473D1 (de) 2005-09-30 2009-02-05 Hoffmann La Roche Nnrt-inhibitoren
AU2006303368B2 (en) 2005-10-19 2011-05-26 F. Hoffmann-La Roche Ag Non-Nucleoside Reverse Transcriptase Inhibitors
BRPI0617482A2 (pt) 2005-10-19 2011-07-26 Hoffmann La Roche compostos inibidores de transcriptase reversa nço-nucleosÍdeos de n-fenil fenilacetamida, composiÇço farmacÊutica contendo os referidos compostos bem como seus usos
MX2008011220A (es) * 2006-03-07 2008-09-11 Array Biopharma Inc Compuestos de pirazol heterobiciclicos y metodos de uso.
WO2008111010A1 (fr) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Dérivés de pyrazolo(3,4-b)pyridine comme inhibiteurs de phosphodiestérase
JP5732036B2 (ja) * 2009-03-19 2015-06-10 メディカル リサーチ カウンシル テクノロジーＭｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ Ｃｏｕｎｃｉｌ Ｔｅｃｈｎｏｌｏｇｙ 化合物

Also Published As

Publication number Publication date
EP2057125B1 (fr) 2011-03-30
RU2451676C2 (ru) 2012-05-27
TW200817397A (en) 2008-04-16
AU2007286345A1 (en) 2008-02-21
KR101401811B1 (ko) 2014-05-29
PE20080734A1 (es) 2008-06-14
WO2008019968A1 (fr) 2008-02-21
RU2009109354A (ru) 2010-09-27
IL196655A0 (en) 2009-11-18
MX2009001198A (es) 2009-02-11
PT2057125E (pt) 2011-05-31
BRPI0715193A2 (pt) 2013-10-01
IL196655A (en) 2012-09-24
ES2360893T3 (es) 2011-06-10
CA2658984C (fr) 2014-12-02
CA2658984A1 (fr) 2008-02-21
JP2010500392A (ja) 2010-01-07
JP5216768B2 (ja) 2013-06-19
KR20090040438A (ko) 2009-04-24
CN101501002B (zh) 2012-06-27
ATE503744T1 (de) 2011-04-15
CN101501002A (zh) 2009-08-05
US20110059975A1 (en) 2011-03-10
US20080045511A1 (en) 2008-02-21
TWI417293B (zh) 2013-12-01
DE602007013573D1 (de) 2011-05-12
US8063064B2 (en) 2011-11-22
PL2057125T3 (pl) 2011-09-30
US7713974B2 (en) 2010-05-11
CL2007002346A1 (es) 2008-03-14
AU2007286345B2 (en) 2012-03-08
DK2057125T3 (da) 2011-05-16
AR062366A1 (es) 2008-11-05
EP2057125A1 (fr) 2009-05-13

Similar Documents

Publication Publication Date Title
NO20090405L (no) Ikke-nukleoside revers transcriptase inhibitorer
MX2009005881A (es) Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
NO20092636L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
MX2009009920A (es) Inhibidores no nucleosidos de transcriptasa inversa.
GEP20156368B (en) Non-nucleoside reverse transcriptase inhibitors
WO2008054605A3 (fr) Inhibiteurs de transcriptase inverse non nucléosidique
EP2041159B8 (fr) Composes macrocycliques en tant qu'agents antiviraux
WO2007146230A3 (fr) Inhibiteurs de transcriptase inverse non nucléosidiques
NO20090628L (no) Pyridizinon derivativater
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20045152L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
CL2008003819A1 (es) Compuestos derivados del acido 2-cetoamino benzoico sustituido, inhibidores del virus de la hepatitis c; composicion farmaceutica; y su uso en el tratamiento de una infeccion por vhc.
TN2010000212A1 (en) Inhibitors of human immunodeficiency virus replication
NO20080913L (no) HIV-revers-transriptaseinhibitorer
NO20073404L (no) Kaliumsalt av en HIV-integraseinhibitor
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20063958L (no) HIV integrase inhibitorer
NO20081217L (no) Nye benzotiazolonderivater
MX2010006397A (es) Compuestos heterociclicos antivirales.
EA201170537A1 (ru) Ингибиторы вич-интегразы
TW200603783A (en) Non-nucleoside reverse transcriptase inhibitors
EP2033954A4 (fr) Composé 6-(benzyle substituté par hétérocycle)-4-oxoquinoline et utilisation de celui-ci comme inhibiteur de l'intégrase du vih
WO2011025683A8 (fr) Inhibiteurs de l'intégrase du vih
MX2009010932A (es) Inhibidores no nucleosidos de transcriptasa inversa.
MX2009012704A (es) Inhibidores de transcriptasa inversa de no nucleosidos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application